Weighing Alli's impact. Eating disorder patients might be tempted to abuse the first FDA-approved nonprescription diet pill.
Autor: | Cumella EJ; Remuda Programs for Eating Disorders, USA. edward.cumella@remudaranch.com, Hahn J, Woods BK |
---|---|
Jazyk: | angličtina |
Zdroj: | Behavioral healthcare [Behav Healthc] 2007 Jun; Vol. 27 (6), pp. 32-4. |
Databáze: | MEDLINE |
Externí odkaz: |